Unconventional AI vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Unconventional AI

EmergingArtificial Intelligence

Neuromorphic Computing

Raised $475M seed at $4.5B valuation (Dec 2025) from a16z, Lightspeed, Lux, and Jeff Bezos. Founded by Naveen Rao (sold Nervana to Intel, MosaicML to Databricks). Analog neuromorphic compute.

About

Unconventional AI is developing analog neuromorphic AI chips inspired by the human brain — the most pedigreed founder team attempting the brain-inspired computing approach. Founded by Naveen Rao, who previously founded Nervana Systems (sold to Intel for ~$350 million) and MosaicML (sold to Databricks for $1.3 billion), the company raised $475 million in seed financing at a $4.5 billion valuation in December 2025 from Andreessen Horowitz, Lightspeed Venture Partners, Lux Capital, and Jeff Bezos.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.